PDT Partners’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-22,873
Closed -$1.26M 794
2021
Q1
$1.26M Buy
22,873
+20,131
+734% +$1.33M 0.09% 328
2020
Q4
$199K Buy
2,742
+1,865
+213% +$219K 0.01% 612
2020
Q3
$173K Sell
877
-1,217
-58% -$306K 0.01% 645
2020
Q2
$586K Sell
2,094
-2,219
-51% -$518K 0.04% 376
2020
Q1
$768K Buy
4,313
+412
+11% +$88.3K 0.06% 274
2019
Q4
$958K Buy
3,901
+618
+19% +$114K 0.06% 290
2019
Q3
$387K Sell
3,283
-392
-11% -$59.3K 0.02% 357
2019
Q2
$595K Buy
+3,675
New +$699K 0.04% 293
2018
Q3
Sell
-2,700
Closed -$1.27M 475
2018
Q2
$1.27M Sell
2,700
-735
-21% -$389K 0.05% 300
2018
Q1
$2.03M Sell
3,435
-690
-17% -$428K 0.07% 272
2017
Q4
$2.24M Buy
4,125
+2,331
+130% +$1.06M 0.07% 283
2017
Q3
$752K Buy
+1,794
New +$550K 0.02% 386
2017
Q2
Sell
-1,200
Closed -$367K 517
2017
Q1
$367K Buy
+1,200
New +$294K 0.02% 406
2015
Q4
Sell
-1,800
Closed -$207K 428
2015
Q3
$207K Buy
1,800
+208
+13% +$36.6K ﹤0.01% 1146
2015
Q2
$368K Buy
+1,592
New +$307K 0.01% 1072

Other funds holding ASMB

PDT Partners's ASMB Position: Q2 2021 in Review

PDT Partners sold out of Assembly Biosciences (ASMB) in Q2 2021, closing a stake of 22,873 shares — an estimated $1.26M sold.

PDT Partners first reported a position in ASMB in Q2 2015 and held it in 15 quarters. The position peaked at $2.24M in Q4 2017. 91 funds tracked by Wall St. Rank hold ASMB as of Q2 2021.

  • PDT Partners reported no remaining Assembly Biosciences position as of Q2 2021 after selling out during the quarter.
  • PDT Partners sold 22,873 Assembly Biosciences shares in Q2 2021, an estimated $1.26M.
  • PDT Partners first reported a position in Assembly Biosciences in Q2 2015 and held it in 15 quarters.
  • PDT Partners's Assembly Biosciences position peaked at $2.24M in Q4 2017.
  • 91 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2021.

Based on PDT Partners's 13F filing for Q2 2021, filed 16 Aug 2021.